首頁 > 市場調查報告書 > 製藥

動物用醫藥

市場調查報告書

商品編碼

1716532

動物寄生蟲殺蟲劑市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

Animal Parasiticides Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年03月31日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2024 年全球動物寄生蟲殺蟲劑市場價值為 129 億美元，預計 2025 年至 2034 年的複合年成長率為 5.3%。這一成長受到全球動物數量的增加、寵物擁有量的增加、寄生蟲感染的流行以及動物保健支出的增加的推動。腸道寄生蟲和蜱傳疾病等傳染病繼續構成健康風險，導致對預防和治療的需求增加。動物寄生蟲殺蟲劑，包括外用溶液、口服藥物和注射劑，在控制寄生蟲感染和保障動物健康方面發揮至關重要的作用。寵物主人將預防寄生蟲放在首位，這導致狗和貓等伴侶動物對這些產品的需求激增。畜牧業也依賴抗寄生蟲藥物來維持動物健康和維持糧食生產。遠距醫療平台和即時診斷等獸醫學技術的進步也促進了市場擴張。

動物寄生蟲殺滅劑依其功能分類，主要包括外寄生蟲殺滅劑、內寄生蟲殺滅劑和內寄生蟲殺滅劑。外寄生蟲殺蟲劑領域包括澆注劑、口服藥片、點滴劑、噴霧劑、浸劑、耳標和項圈，2024 年的收入最高，達到 70 億美元。跳蚤、蜱蟲和蟎蟲等外部寄生蟲的廣泛存在持續推動著對這些治療的需求，特別是在氣候變遷的地區。畜牧農民和寵物主人依靠這些殺寄生蟲劑來有效控制寄生蟲。點滴治療和噴霧等配方創新提高了依從性和功效，進一步刺激了市場需求。政府為確保更好的動物健康和衛生而採取的措施也有助於外寄生蟲殺蟲劑保持強大的市場地位。

市場範圍
起始年份	2024
預測年份	2025-2034
起始值	129億美元
預測值	218億美元
複合年成長率	5.3%

動物寄生蟲殺蟲劑市場按類型進一步細分為非處方藥 (OTC) 和處方藥。 2024 年，處方藥市場佔據主導地位，市佔率達 74.1%。處方類殺蟲劑需要獸醫監督，以確保為動物製定量身定做的治療方案。這些產品通常更加精緻，專門用於治療目標寄生蟲感染，與非處方藥替代品相比更有效。它們的效力和特異性使它們成為獸醫和寵物主人的首選。

根據動物類型對市場進行細分，將殺寄生蟲劑分為伴侶動物和農場動物。 2024 年，伴侶動物細分市場的收入佔有率最高，為 56.9%。寵物收養數量的增加和人們對寄生蟲疾病預防意識的增強推動了對這些治療的需求。跳蚤、蜱蟲、蟎蟲和蠕蟲等寄生蟲經常影響寵物，導致各種健康問題。製造商不斷開發創新解決方案來滿足日益成長的需求。

市場進一步依藥物類別分類，包括化學合成、擬除蟲菊酯、大環內酯、有機磷酸酯、苯並咪唑等。化學合成領域在 2024 年規模最大，預計在預測期內的複合年成長率為 5%。這些殺寄生蟲劑因其廣譜活性、有效性和價格實惠而被廣泛使用。它們在寵物護理和牲畜管理中發揮著至關重要的作用，支持動物健康和生產力。

依照最終用途，市場分為動物農場、獸醫醫院和診所以及家庭護理機構。 2024 年，獸醫院和診所佔據了最大的市場佔有率，預計到 2034 年將達到 127 億美元。這些機構僱用訓練有素的專業人員，確保對寄生蟲感染進行準確的診斷和治療。他們在提供處方治療、先進診斷和專業護理方面發揮的作用鞏固了其在市場上的主導地位。寵物保險的普及率不斷提高以及獸醫護理支出的增加也促進了這一領域的持續擴張。

從地理位置來看，北美在 2024 年佔據動物寄生蟲殺蟲劑市場的主導地位，佔有 37.2% 的佔有率，預計在預測期內將以 4% 的複合年成長率成長。伴侶動物和牲畜數量的增加，以及政府對動物健康計畫的大力支持，推動了該地區對抗寄生蟲產品的需求。光是美國市場在 2021 年的價值就為 38 億美元，2022 年成長至 39 億美元，2023 年達到 42 億美元。隨著獸藥的不斷進步和對動物保健的投資不斷增加，市場將保持上升趨勢。

產業生態系統分析
產業衝擊力
- 成長動力
  - 動物保健支出增加
  - 養寵物的趨勢日益成長
  - 人類食品中對動物性蛋白質的需求迅速增加
  - 人畜共通傳染病和跨界疾病發生率不斷上升
  - 動物疾病發生率不斷上升
- 產業陷阱與挑戰
  - 食用動物殺寄生蟲劑消費限制
  - 寵物照護費用高
成長潛力分析
監管格局
2024 年各產品定價分析
波特的分析
PESTEL分析

第4章：競爭格局

介紹
公司市佔率分析
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
策略儀表板

第5章：市場估計與預測：按產品，2021 年至 2034 年

主要趨勢
殺外寄生蟲劑
- 澆注式和點塗式
- 口服錠劑
- 噴霧劑
- 沾醬
- 耳標
- 項圈
- 其他殺外寄生蟲劑
體內寄生蟲殺滅劑
- 口服液
- 口服固體藥物
- 注射劑
- 飼料添加劑
- 其他體內寄生蟲殺滅劑
內蟲殺滅劑

第6章：市場估計與預測：按類型，2021 年至 2034 年

主要趨勢
場外交易（OTC）
處方

第7章：市場估計與預測：依動物類型，2021 年至 2034 年

主要趨勢
伴侶動物
- 狗
- 貓
- 馬匹
- 其他伴侶動物
農場動物
- 家禽
- 豬
- 牛
- 綿羊和山羊
- 其他農場動物

第 8 章：市場估計與預測：按藥物類別，2021 年至 2034 年

主要趨勢
化學合成
大環內酯
擬除蟲菊酯
有機磷酸酯
苯並咪唑類
其他藥物類別

第9章：市場估計與預測：依最終用途，2021 年至 2034 年

主要趨勢
獸醫醫院和診所
動物農場
居家照護環境

第10章：市場估計與預測：按地區，2021 年至 2034 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 俄羅斯
- 波蘭
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- 土耳其

第 11 章：公司簡介

Boehringer Ingelheim International
Bimeda
Biogenesis Bagó
Ceva Sante Animal
Dechra Pharmaceuticals
Elanco Animal Health
Merck
Norbrook Laboratories
Neogen Corporation
Ourofino Saude Animal
Phibro Animal Health
PetIQ
Virbac
Vetoquinol
Zoetis

簡介目錄

Product Code: 2114

The Global Animal Parasiticides Market was valued at USD 12.9 billion in 2024 and is projected to grow at a CAGR of 5.3% from 2025 to 2034. This growth is fueled by the rising global animal population, increasing pet ownership, the prevalence of parasitic infections, and higher spending on animal healthcare. Contagious diseases such as intestinal parasites and tick-borne illnesses continue to pose health risks, prompting increased demand for preventive and curative treatments. Animal parasiticides, including topical solutions, oral medications, and injectables, play a crucial role in controlling infestations and safeguarding animal health. Pet owners are prioritizing parasite prevention, which has led to a surge in demand for these products in companion animals like dogs and cats. The livestock industry also relies on antiparasitic drugs to maintain animal health and sustain food production. Technological advancements in veterinary medicine, such as telemedicine platforms and point-of-care diagnostics, are also contributing to market expansion.

Animal parasiticides are categorized based on their function, with key segments including ectoparasiticides, endoparasiticides, and endectocides. The ectoparasiticides segment, which includes pour-ons, oral tablets, spot-ons, sprays, dips, ear tags, and collars, generated the highest revenue in 2024, amounting to USD 7 billion. The widespread presence of external parasites like fleas, ticks, and mites continues to drive demand for these treatments, particularly in regions with varied climates. Livestock farmers and pet owners rely on these parasiticides for effective parasite control. Innovations in formulations, including spot-on treatments and sprays, have improved adherence and efficacy, further boosting market demand. Government initiatives aimed at ensuring better animal health and hygiene also contribute to the strong market position of ectoparasiticides.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$12.9 Billion
Forecast Value	$21.8 Billion
CAGR	5.3%

The animal parasiticides market is further segmented by type into over-the-counter (OTC) and prescription products. In 2024, the prescription segment dominated with a 74.1% market share. Prescription-based parasiticides require veterinary oversight, ensuring tailored treatment plans for animals. These products are typically more refined and specifically designed to treat targeted parasite infestations, making them more effective compared to OTC alternatives. Their potency and specificity have made them the preferred choice among veterinarians and pet owners.

Market segmentation by animal type classifies parasiticides into companion animals and farm animals. In 2024, the companion animals segment held the highest revenue share at 56.9%. The increasing number of pet adoptions and the growing awareness of parasitic disease prevention have fueled demand for these treatments. Parasites such as fleas, ticks, mites, and worms frequently affect pets, leading to various health concerns. Manufacturers continue to develop innovative solutions to meet this rising demand.

The market is further categorized by drug class, including chemical synthetic, pyrethroids, macrocyclic lactones, organophosphates, benzimidazoles, and others. The chemical synthetic segment was the largest in 2024 and is expected to grow at a CAGR of 5% over the forecast period. These parasiticides are widely used due to their broad-spectrum activity, effectiveness, and affordability. They play a vital role in both pet care and livestock management, supporting animal health and productivity.

In terms of end use, the market is divided into animal farms, veterinary hospitals and clinics, and home care settings. Veterinary hospitals and clinics accounted for the largest market share in 2024 and are projected to reach USD 12.7 billion by 2034. These facilities employ trained professionals who ensure accurate diagnosis and treatment of parasitic infections. Their role in providing prescription-based treatments, advanced diagnostics, and specialized care has solidified their dominance in the market. The growing adoption of pet insurance and higher expenditure on veterinary care also contribute to this segment's continued expansion.

Geographically, North America led the animal parasiticides market in 2024, holding a 37.2% share, and is expected to grow at a 4% CAGR over the forecast period. The increasing number of companion and livestock animals, along with strong government support for animal health initiatives, has driven demand for antiparasitic products in the region. The U.S. market alone was valued at USD 3.8 billion in 2021, grew to USD 3.9 billion in 2022, and reached USD 4.2 billion in 2023. With continuous advancements in veterinary pharmaceuticals and increasing investments in animal healthcare, the market is set to maintain its upward trajectory.

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing in animal healthcare expenditure
  - 3.2.1.2 Growing trend of adoption of pet animals
  - 3.2.1.3 Rapidly increasing demand for animal protein in human food
  - 3.2.1.4 Increasing incidences of zoonotic and transboundary diseases
  - 3.2.1.5 Increasing prevalence of animal diseases
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Restrictions on parasiticide consumption in food animals
  - 3.2.2.2 High pet care cost
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pricing analysis, by product, 2024
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2034 ($ Mn)

5.1 Key trends
5.2 Ectoparasiticides
- 5.2.1 Pour-ons and spot-ons
- 5.2.2 Oral tablets
- 5.2.3 Sprays
- 5.2.4 Dips
- 5.2.5 Ear tags
- 5.2.6 Collars
- 5.2.7 Other ectoparasiticides
5.3 Endoparasiticides
- 5.3.1 Oral liquids
- 5.3.2 Oral solids
- 5.3.3 Injectables
- 5.3.4 Feed additives
- 5.3.5 Other endoparasiticides
5.4 Endectocides

Chapter 6 Market Estimates and Forecast, By Type, 2021 – 2034 ($ Mn)

6.1 Key trends
6.2 Over the counter (OTC)
6.3 Prescription

Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 – 2034 ($ Mn)

7.1 Key trends
7.2 Companion animals
- 7.2.1 Dogs
- 7.2.2 Cats
- 7.2.3 Horses
- 7.2.4 Other companion animals
7.3 Farm animals
- 7.3.1 Poultry
- 7.3.2 Swine
- 7.3.3 Cattle
- 7.3.4 Sheep and goats
- 7.3.5 Other farm animals

Chapter 8 Market Estimates and Forecast, By Drug Class, 2021 – 2034 ($ Mn)

8.1 Key trends
8.2 Chemical synthetic
8.3 Macrocyclic lactones
8.4 Pyrethroids
8.5 Organophosphates
8.6 Benzimidazoles
8.7 Other drug classes

Chapter 9 Market Estimates and Forecast, By End Use, 2021 – 2034 ($ Mn)

9.1 Key trends
9.2 Veterinary hospitals and clinics
9.3 Animal farms
9.4 Home care settings

Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)

10.1 Key trends
10.2 North America
- 10.2.1 U.S.
- 10.2.2 Canada
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 France
- 10.3.4 Spain
- 10.3.5 Italy
- 10.3.6 Russia
- 10.3.7 Poland
10.4 Asia Pacific
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 South Korea
10.5 Latin America
- 10.5.1 Brazil
- 10.5.2 Mexico
- 10.5.3 Argentina
10.6 Middle East and Africa
- 10.6.1 South Africa
- 10.6.2 Saudi Arabia
- 10.6.3 Turkey